Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938312 · ClinicalTrials.gov registry record · NA
Journey to Better Health
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 409
- Enrollment target
NCT02938312: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02938312 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 409 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02938312, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 409 participants
- Enrollment target
Study Summary
This study is being conducted in 8 rural counties in Alabama and Mississippi (4 per state). Approximately 400 overweight or obese African American women living in the selected counties will participate in a 2-year weight loss study.
Primary Outcome
Measured weight (nearest kg)
Interventions
- BEHAVIORAL Weight Loss Only
- BEHAVIORAL Weight Loss Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02938312 record still lists
NCT02938312 is an interventional study that assigns participants to a tested intervention. The registered 409 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Weight Loss Only is the first listed.
NCT02938312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02938312 about?
NCT02938312 is a clinical study titled "Journey to Better Health". This study is being conducted in 8 rural counties in Alabama and Mississippi (4 per state). Approximately 400 overweight or obese African American women living in the selected counties will participate in a 2-year weight loss study.
What is the current status of trial NCT02938312?
This trial is currently completed. It is a NA study. The enrollment target is 409 participants. The study started on 2010-08. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02938312?
The interventions under investigation include: Weight Loss Only (BEHAVIORAL), Weight Loss Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT02938312?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02938312's enrollment target sits among peer trials
409 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717334 · 409 participants
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia